HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Soichiro Sue Selected Research

Soichiro Sue Research Topics

Disease

4Neoplasms (Cancer)
01/2020 - 01/2015
2Inflammation (Inflammations)
04/2021 - 12/2017
2Hypersensitivity (Allergy)
02/2021 - 01/2017
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 01/2018
2Carcinogenesis
01/2020 - 01/2015
2Infections
04/2018 - 01/2017
1Abdominal Pain (Pain, Abdominal)
04/2024
1Fibrosis (Cirrhosis)
04/2021
1Sclerosing Cholangitis
04/2021
1Diarrhea
02/2021
1Pancreatitis
01/2020
1Carcinoma in Situ
01/2020
1Peptic Ulcer (Peptic Ulcers)
01/2018
1Ulcer
01/2018
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
01/2018
1Metaplasia
12/2017

Drug/Important Bio-Agent (IBA)

31- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA
02/2021 - 01/2017
2Cadherins (E-Cadherin)IBA
04/2021 - 01/2020
2Metronidazole (Metric)FDA LinkGeneric
02/2021 - 01/2017
2Penicillins (Penicillin)FDA Link
02/2021 - 01/2017
1sitafloxacinIBA
02/2021
1Proteins (Proteins, Gene)FDA Link
01/2018
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2018
1Proton Pump InhibitorsIBA
01/2018
1Esomeprazole (Nexium)FDA Link
01/2018
1Messenger RNA (mRNA)IBA
12/2017
1spasmolytic polypeptideIBA
12/2017
1CarcinogensIBA
12/2017
1Complementary RNA (cRNA)IBA
12/2017
1Conditioned Culture MediaIBA
11/2017
1JNK Mitogen-Activated Protein KinasesIBA
11/2017
1Clarithromycin (Biaxin)FDA LinkGeneric
01/2017

Therapy/Procedure

3Therapeutics
04/2024 - 01/2015
1Drug Therapy (Chemotherapy)
01/2020
1Duration of Therapy
04/2018